Effect of ibuprofen in combination with omega 3 in the management of temporomandibular disorder

A clinical trial

Authors

  • Amna Umar Department of Pharmacology, Peshawer Medical College, Peshawar, Riphah International University, Islamabad.
  • Erum Rehman Department of Pharmacology, Peshawer Medical College, Peshawar, Riphah International University, Islamabad.
  • Shafaq Zafar Department of Pharmacology, Peshawer Medical College, Peshawar, Riphah International University, Islamabad.
  • Amber Javaid Department of Pharmacology, Peshawer Medical College, Peshawar, Riphah International University, Islamabad.
  • Riaz Nasim Department of Pharmacology, Peshawer Medical College, Peshawar, Riphah International University, Islamabad.
  • Zia Ul Arifeen Resident in department of prosthodontics, Post graduate medical institute, Peshawar.

Keywords:

ibuprofen, omega 3, analgesic, dentofacial illnesses, temporomandibular joint disorder

Abstract

Introduction: Disorders of the temporomandibular joint (TMD) are dentofacial illnesses that can be caused by extra- or intra-articular disease. TMD is treated with a variety of pharmaceutical preparations, including non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and steroids. Many of these drugs are used together to reduce the symptoms and retard the progression of the disease to chronic illness. Aims & Objectives: The aim of the current study is to compare the effectiveness of ibuprofen in combination with omega 3 in the management of TMJ disorder. Methodology: A randomized control trial was conducted among the patients of temporomandibular disorder presenting to OPD and oral medicine departments at Peshawar Dental College and Khyber College of Dentistry. A total of 58 patients were randomly selected. The data was collected through a self-structured questionnaire including the Numerical Rating Scale (NRS) for pain. The pain was recorded on day 0 before the commencement of the treatment. Ibuprofen 400mg BD along with omega 3 1000mg OD was given. The participants were given the drugs for a period of 30 days.

Downloads

Download data is not yet available.

References

Barbar-Smiley, F., Cooper, A., Edelheit, B., Flanagan, E., Gillespie-Taylor, M., Hays, K., . . . Sullivan, N. Supplementary Appendix 3: Evidence Report 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis (JIA): Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint (TMJ) Arthritis and Systemic JIA.

Bjørklund, G., Aaseth, J., Doşa, M. D., Pivina, L., Dadar, M., Pen, J. J., & Chirumbolo, S. (2019). Does diet play a role in reducing nociception related to inflammation and chronic pain? Nutrition, 66, 153-165.

Breivik, E. K., Björnsson, G. A., & Skovlund, E. (2000). A comparison of pain rating scales by sampling from clinical trial data. The Clinical journal of pain, 16(1), 22-28.

Cetira Filho, E. L., Silva, P. G. B., Wong, D. V. T., Choquenaira-Quispe, C., Cesário, F. R. A. S., de Sousa Nogueira, G., . . . Costa, F. W. G. (2022). Effect of preemptive photobiomodulation associated with nimesulide on the postsurgical outcomes, oxidative stress, and quality of life after third molar surgery: a randomized, split-mouth, controlled clinical trial. Clinical Oral Investigations, 26(12), 6941-6960.

Guo, H., Fang, W., Li, Y., Ke, J., Deng, M., Meng, Q., . . . Long, X. (2015). Up‐regulation of proteoglycan 4 in temporomandibular osteoarthritic synovial cells by hyaluronic acid. Journal of Oral Pathology & Medicine, 44(8), 622-627.

Jahromi, B., Pirvulescu, I., Candido, K. D., & Knezevic, N. N. (2021). Herbal medicine for pain management: efficacy and drug interactions. Pharmaceutics, 13(2), 251.

Maqbool, M., Fekadu, G., Jiang, X., Bekele, F., Tolossa, T., Turi, E., . . . Fanta, K. (2021). An up to date on clinical prospects and management of osteoarthritis. Annals of Medicine and Surgery, 72, 103077.

Porporatti, A. L., Costa, Y. M., Reus, J. C., Stuginski‐Barbosa, J., Conti, P. C. R., Velly, A. M., & De Luca Canto, G. (2019). Placebo and nocebo response magnitude on temporomandibular disorder‐related pain: A systematic review and meta‐analysis. Journal of Oral Rehabilitation, 46(9), 862-882.

Razavi, B. M., Ghasemzadeh Rahbardar, M., & Hosseinzadeh, H. (2021). A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytotherapy Research, 35(12), 6489-6513.

Segù, M. (2022). The TMJ Troubles and Their Nutritional Consequences. In Treatment Dilemmas for Vulnerable Patients in Oral Health (pp. 67-75): Springer.

Singer, E., & Dionne, R. (1997). A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. Journal of orofacial pain, 11(2).

Singgih, M. F., Achmad, H., Sukmana, B. I., Carmelita, A. B., Putra, A. P., Ramadhany, S., & Putri, A. P. (2020). A Review of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Medications in Dentistry: Uses and Side Effects. Systematic Reviews in Pharmacy, 11(5), 293-298.

Siriarchavatana, P., Kruger, M. C., Miller, M. R., Tian, H. S., & Wolber, F. M. (2019). The preventive effects of greenshell mussel (Perna canaliculus) on early-stage metabolic osteoarthritis in rats with diet-induced obesity. Nutrients, 11(7), 1601.

Verma, U. (2020). Impact Of CNS Depressants & Nsaids Medications In Fibromyalgia Disease.

Wilkinson, A. (1980). Naproxen levels in preterm infants after maternal treatment. The Lancet, 316(8194), 591-592.

Wu, M., Cai, J., Yu, Y., Hu, S., Wang, Y., & Wu, M. (2021). Therapeutic agents for the treatment of temporomandibular joint disorders: progress and perspective. Frontiers in Pharmacology, 11, 596099.

Published

09-01-2023

How to Cite

Umar, A., Rehman, E., Zafar, S., Javaid, A., Nasim, R., & Ul Arifeen, Z. (2023). Effect of ibuprofen in combination with omega 3 in the management of temporomandibular disorder: A clinical trial. International Journal of Health Sciences, 6(S9), 4548–4556. Retrieved from https://sciencescholar.us/journal/index.php/ijhs/article/view/13834

Issue

Vol. 6 No. S9 (2022)

Section

Peer Review Articles
Copyright & Licensing

Copyright (c) 2023 International journal of health sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.

Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.